A Trial of HR17031 Injection With Hepatic Insufficiency

NCT05151705 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Improved Glycemic Control in Patients With Type 2 Diabetes

Interventions

DRUG: HR17031 injection
DRUG: HR17031 injection
DRUG: HR17031 injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.